| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |